Merkel cell carcinoma developing after antithymocyte globulin and cyclosporine therapy for aplastic anemia

Anti-Cancer Drugs

Volumn 14, Issue 3, 2003, Pages 251-253

  Takabayashi, Maki ^a,b   Sakai, Rika ^a   Sakamoto, Hiroshi ^a   Iemoto, Youichi ^a   Kanamori, Heiwa ^b   Inayama, Yoshiaki ^b   Ishigatsubo, Yoshiaki ^b  

^a Fujisawa City Hospital   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Antithymocyte globulin; Apiastic anemia; Immunosuppressive therapy; Merkel cell carcinoma; Second cancer

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY;

AGED; APLASTIC ANEMIA; ARTICLE; CASE REPORT; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MERKEL CELL TUMOR; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; SECOND CANCER;

AGED; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CARCINOMA, MERKEL CELL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 0037359461     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200303000-00010     Document Type: Article

References (10)

1. Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE, et al. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood 1995; 85:283-290.
2. Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, McCann S, et al. Prospective randomized multicenter study comparing cyclosporine alone versus the combination of antithymocyte globulin and cyclosporine for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anemia Working Party. Blood 1999; 93:2191-2199.
3. Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al. Malignant tumors occurring after treatment of aplastic anemia. N Eng J Med 1993; 329:1152-1157.
4. Gooptu C, Woollons A, Ross J, Price M, Wojnarowska F, Morris PJ, et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997; 137:637-641.
5. Williams RH, Morgan MB, Mathieson IM, Rabb H. Merkel cell carcinoma in a renal transplant patient: increased incidence? Transplantation 1998; 65:1396-1397.
6. Gilaberte M, Pujol RM, Sierra J, Matias-Guiu X, Isern J, Serret P, et al. Merkel cell carcinoma developing after bone marrow transplantation. Dermatology 2000; 201:80-82.
7. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105:107-110.
8. Schmidt U, Muller U, Metz KA, Leder LD. Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of small cell type and small cell carcinoma of the lung. Am J Dermatopathol 1998; 20:346-351.
9. Penn I, First MR. Merkel cell carcinoma in organ recipients. Transplantation 1999; 68:1717-1721.
10. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biophys 1995; 31:315-323.